- Filed
- Jun 10, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 15, 2023 | 3.98M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 3.93M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 1.62M sh |
| Operating Cash Flow restated | Q1 2023 · Mar 31, 2023 | −$6.19M |
| Operating Cash Flow restated | Q1 2023 · Mar 31, 2022 | $116.82K |
| Stockholders Equity restated | Q1 2023 · Mar 31, 2023 | −$20.79M |
| Stockholders Equity restated | Q1 2023 · Dec 31, 2022 | −$17.1M |
| Stockholders Equity restated | Q1 2023 · Mar 31, 2022 | $286.65K |
| Stockholders Equity restated | Q1 2023 · Dec 31, 2021 | −$55.69K |
| Current Liabilities restated | Q1 2023 · Mar 31, 2023 | $23.82M |
| Current Liabilities restated | Q1 2023 · Dec 31, 2022 | $24.48M |
| Total Liabilities restated | Q1 2023 · Mar 31, 2023 | $23.82M |
| Total Liabilities restated | Q1 2023 · Dec 31, 2022 | $24.48M |
| Current Assets restated | Q1 2023 · Mar 31, 2023 | $2.93M |
| Current Assets restated | Q1 2023 · Dec 31, 2022 | $7.17M |
| Total Assets restated | Q1 2023 · Mar 31, 2023 | $3.04M |
| Total Assets restated | Q1 2023 · Dec 31, 2022 | $7.37M |
| Eps Diluted restated | Q1 2023 · Mar 31, 2023 | −$0.94 |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | $0.19 |
| Eps Basic restated | Q1 2023 · Mar 31, 2023 | −$0.94 |
| Eps Basic restated | Q1 2023 · Mar 31, 2022 | $0.19 |
| Sga Expense restated | Q1 2023 · Mar 31, 2023 | $603.48K |
| Sga Expense restated | Q1 2023 · Mar 31, 2022 | $393.25K |
| Net Income restated | Q1 2023 · Mar 31, 2023 | −$3.68M |
| Net Income restated | Q1 2023 · Mar 31, 2022 | $308.3K |
| Operating Income restated | Q1 2023 · Mar 31, 2023 | −$3.43M |
| Operating Income restated | Q1 2023 · Mar 31, 2022 | $390.26K |
| Gross Profit restated | Q1 2023 · Mar 31, 2023 | $3.94M |
| Gross Profit restated | Q1 2023 · Mar 31, 2022 | $6.14M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2023 | $2.64M |
| Cost Of Revenue restated | Q1 2023 · Mar 31, 2022 | $2.18M |